General Info

Located in San Francisco, Calif., FibroGen Inc. is a research-based biotechnology company using its expertise in connective tissue growth factor (CTGF) and hypoxia-inducible factor (HIF) biology. It discovers, develops and commercializes novel therapeutics for serious unmet medical needs. The company's major investors include Adage Capital Management, Brookside Capital Partners, Corriente Biotechnology Partners, Duquesne Capital Management, Franklin Templeton, Goldman Sachs, IBELIN PTE Investments, etc. Some of its strategic alliances are Astellas Pharma Inc. and Medarex Inc.